DRNA — DICERNA PHARMACEUTICALS INC
DRNA (DICERNA PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 31 funds have reported positions historically, with the sum of their latest reported stakes valued at $406.09M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q3 2021 | 3.71M | $74.74M | 0.00% | Add |
| T. Rowe Price Associates history | Q3 2021 | 2.68M | $54.08M | 0.01% | New |
| Morgan Stanley history | Q3 2021 | 1.74M | $35.00M | 0.01% | New |
| JPMorgan Chase & Co history | Q3 2021 | 1.54M | $31.10M | 0.01% | New |
| Maverick Capital history | Q3 2021 | 1.31M | $26.42M | 0.27% | New |
| Geode Capital Management history | Q3 2021 | 1.19M | $24.00M | 0.00% | New |
| UBS Group AG history | Q3 2021 | 1.10M | $22.20M | 0.01% | New |
| Goldman Sachs Group history | Q3 2021 | 798.54K | $16.10M | 0.00% | New |
| Northern Trust Corp history | Q3 2021 | 764.31K | $15.41M | 0.00% | New |
| Point72 Asset Management history | Q3 2021 | 635.40K | $12.81M | 0.06% | New |
| Two Sigma Investments history | Q3 2021 | 575.11K | $11.59M | 0.03% | New |
| Wellington Management Group history | Q3 2021 | 533.60K | $10.76M | 0.00% | New |
| Charles Schwab Investment Management history | Q3 2021 | 517.26K | $10.43M | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q3 2021 | 513.61K | $10.35M | 0.00% | New |
| Invesco Ltd history | Q3 2021 | 430.35K | $8.68M | 0.00% | New |
| Millennium Management history | Q3 2021 | 361.22K | $7.28M | 0.01% | New |
| BNY Mellon history | Q3 2021 | 282.91K | $5.70M | 0.00% | New |
| Balyasny Asset Management history | Q3 2021 | 277.95K | $5.60M | 0.02% | New |
| Citadel Advisors history | Q3 2021 | 261.20K | $5.27M | 0.00% | New |
| Bank of America Corp history | Q3 2021 | 135.30K | $2.73M | 0.00% | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2021 | Q2 2021 | Q3 2021 |
|---|---|---|---|
| Vanguard Group | 3.57M | 3.62M | 3.71M |
| T. Rowe Price Associates | — | — | 2.68M |
| Morgan Stanley | — | — | 1.74M |
| JPMorgan Chase & Co | — | — | 1.54M |
| Maverick Capital | — | — | 1.31M |
| Geode Capital Management | — | — | 1.19M |
| UBS Group AG | — | — | 1.10M |
| Goldman Sachs Group | — | — | 798.54K |
| Northern Trust Corp | — | — | 764.31K |
| Point72 Asset Management | — | — | 635.40K |
| Two Sigma Investments | — | — | 575.11K |
| Wellington Management Group | — | — | 533.60K |
| Charles Schwab Investment Management | — | — | 517.26K |
| Fidelity Management & Research (FMR) | — | — | 513.61K |
| Invesco Ltd | — | — | 430.35K |
| Millennium Management | — | — | 361.22K |
| BNY Mellon | — | — | 282.91K |
| Balyasny Asset Management | — | — | 277.95K |
| Citadel Advisors | — | — | 261.20K |
| Bank of America Corp | — | — | 135.30K |